← Leaderboards
Simon Young
Harvard Medical School
$4,502,912
Attributed
$4,792,359
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,792,359 · 5
By mechanism
R01$2,957,648 · 1
R21$874,443 · 2
R00$747,000 · 1
K99$213,268 · 1
Top collaborators
- Jeffrey Jay Tabor1 shared
- Omid Veiseh1 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Arlene H Sharpe$68,359,602
- Gordon J Freeman$1,587,120
- Lingyin Li$4,140,876
- Jefte M. Drijvers$97,911
- Yiyun Grace Cao$90,874
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyCancer ImmunotherapySurvival RateMalignant NeoplasmsQuality Of LifeCombined Modality TherapyTumorImmunotherapeutic AgentIn SituResponseEffectivenessPre-Clinical ModelChemotherapyDoseDendritic CellsMalignant Mouth NeoplasmDesignImmune ResponseRadiation TherapySpatiotemporalToxic EffectSystemic ToxicityPathway InteractionsImmunotherapy
Grant awards (16)
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$446,690
R01 · FY2025 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$605,357
R01 · FY2024 · DE · contact PI
Engineered bacterial in situ vaccines against oral cancer.$434,170
R21 · FY2024 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$77,282
R01 · FY2024 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$658,892
R01 · FY2023 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$77,282
R01 · FY2023 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$607,926
R01 · FY2022 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$55,779
R01 · FY2022 · DE · contact PI
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy$428,440
R01 · FY2021 · DE · contact PI
STINGel Immunotherapy for Treatment-Resistant Head and Neck Cancer$156,987
R21 · FY2019 · DE · contact PI
STINGel Immunotherapy for Treatment-Resistant Head and Neck Cancer$283,286
R21 · FY2018 · DE · contact PI
The Use of Novel Implantable Cancer Vaccines for the Treatment of Oral Cancer$249,000
R00 · FY2017 · DE · contact PI
The Use of Novel Implantable Cancer Vaccines for the Treatment of Oral Cancer$249,000
R00 · FY2016 · DE · contact PI
The Use of Novel Implantable Cancer Vaccines for the Treatment of Oral Cancer$249,000
R00 · FY2015 · DE · contact PI
The Use of Novel Implantable Cancer Vaccines for the Treatment of Oral Cancer$106,634
K99 · FY2014 · DE · contact PI
The Use of Novel Implantable Cancer Vaccines for the Treatment of Oral Cancer$106,634
K99 · FY2013 · DE · contact PI